161 related articles for article (PubMed ID: 23606280)
61. Alcohol consumption alters Gdnf promoter methylation and expression in rats.
Maier HB; Neyazi M; Neyazi A; Hillemacher T; Pathak H; Rhein M; Bleich S; Goltseker K; Sadot-Sogrin Y; Even-Chen O; Frieling H; Barak S
J Psychiatr Res; 2020 Feb; 121():1-9. PubMed ID: 31710958
[TBL] [Abstract][Full Text] [Related]
62. Cross-link regulation of precursor N-cadherin and FGFR1 by GDNF increases U251MG cell viability.
Tang CX; Gu YX; Liu XF; Tong SY; Ayanlaja AA; Gao Y; Ji GQ; Xiong Y; Huang LY; Gao DS
Oncol Rep; 2018 Jul; 40(1):443-453. PubMed ID: 29750313
[TBL] [Abstract][Full Text] [Related]
63. Deletion of A-antigen in a human cancer cell line is associated with reduced promoter activity of CBF/NF-Y binding region, and possibly with enhanced DNA methylation of A transferase promoter.
Iwamoto S; Withers DA; Handa K; Hakomori S
Glycoconj J; 1999 Oct; 16(10):659-66. PubMed ID: 10972144
[TBL] [Abstract][Full Text] [Related]
64. CAMKK2, Regulated by Promoter Methylation, is a Prognostic Marker in Diffuse Gliomas.
Liu DM; Wang HJ; Han B; Meng XQ; Chen MH; Yang DB; Sun Y; Li YL; Jiang CL
CNS Neurosci Ther; 2016 Jun; 22(6):518-24. PubMed ID: 27012733
[TBL] [Abstract][Full Text] [Related]
65. OCT4 is up-regulated by DNA hypomethylation of promoter in recurrent gliomas.
Wu Y; Sun B; Shi W; Ni L; Chen J; Cai G; Shi J
Neoplasma; 2016; 63(3):378-84. PubMed ID: 26925786
[TBL] [Abstract][Full Text] [Related]
66. DNA hypomethylation of CD133 promoter is associated with recurrent glioma.
Sun B; Wan Z; Shen J; Ni L; Chen J; Cui M; Ni H; Shi W; Shi J
Oncol Rep; 2016 Aug; 36(2):1062-8. PubMed ID: 27374817
[TBL] [Abstract][Full Text] [Related]
67. An analog of a dipeptide-like structure of FK506 increases glial cell line-derived neurotrophic factor expression through cAMP response element-binding protein activated by heat shock protein 90/Akt signaling pathway.
Cen X; Nitta A; Ohya S; Zhao Y; Ozawa N; Mouri A; Ibi D; Wang L; Suzuki M; Saito K; Ito Y; Kawagoe T; Noda Y; Ito Y; Furukawa S; Nabeshima T
J Neurosci; 2006 Mar; 26(12):3335-44. PubMed ID: 16554484
[TBL] [Abstract][Full Text] [Related]
68. DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis.
Foltz G; Yoon JG; Lee H; Ryken TC; Sibenaller Z; Ehrich M; Hood L; Madan A
Oncogene; 2009 Jul; 28(29):2667-77. PubMed ID: 19465937
[TBL] [Abstract][Full Text] [Related]
69. Paracrine regulation of glioma cells invasion by astrocytes is mediated by glial-derived neurotrophic factor.
Shabtay-Orbach A; Amit M; Binenbaum Y; Na'ara S; Gil Z
Int J Cancer; 2015 Sep; 137(5):1012-20. PubMed ID: 25487790
[TBL] [Abstract][Full Text] [Related]
70. Characterization of a promoter for the human glial cell line-derived neurotrophic factor gene.
Baecker PA; Lee WH; Verity AN; Eglen RM; Johnson RM
Brain Res Mol Brain Res; 1999 Jun; 69(2):209-22. PubMed ID: 10366742
[TBL] [Abstract][Full Text] [Related]
71. Epigenetic regulation of human hedgehog interacting protein in glioma cell lines and primary tumor samples.
Shahi MH; Zazpe I; Afzal M; Sinha S; Rebhun RB; Meléndez B; Rey JA; Castresana JS
Tumour Biol; 2015 Apr; 36(4):2383-91. PubMed ID: 25416442
[TBL] [Abstract][Full Text] [Related]
72. Novel structure of the human GDNF gene.
Woodbury D; Schaar DG; Ramakrishnan L; Black IB
Brain Res; 1998 Aug; 803(1-2):95-104. PubMed ID: 9729303
[TBL] [Abstract][Full Text] [Related]
73. Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Schliesser MG; Claus R; Hielscher T; Grimm C; Weichenhan D; Blaes J; Wiestler B; Hau P; Schramm J; Sahm F; Weiß EK; Weiler M; Baer C; Schmidt-Graf F; Schackert G; Westphal M; Hertenstein A; Roth P; Galldiks N; Hartmann C; Pietsch T; Felsberg J; Reifenberger G; Sabel MC; Winkler F; von Deimling A; Meisner C; Vajkoczy P; Platten M; Weller M; Plass C; Wick W
Oncotarget; 2016 Dec; 7(50):82028-82045. PubMed ID: 27880937
[TBL] [Abstract][Full Text] [Related]
74. Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma.
Bao Z; Feng Y; Wang H; Zhang C; Sun L; Yan Z; Liu Q; Guo T; Li M; Yang X; Jiang C; Zhang Q; Jiang T
Oncol Rep; 2014 Jul; 32(1):250-60. PubMed ID: 24842301
[TBL] [Abstract][Full Text] [Related]
75. Coordinate downregulation of a novel imprinted transcript ITUP1 with PEG3 in glioma cell lines.
Maegawa S; Itaba N; Otsuka S; Kamitani H; Watanabe T; Tahimic CG; Nanba E; Oshimura M
DNA Res; 2004 Feb; 11(1):37-49. PubMed ID: 15141944
[TBL] [Abstract][Full Text] [Related]
76. The transcription factor Six2 activates expression of the Gdnf gene as well as its own promoter.
Brodbeck S; Besenbeck B; Englert C
Mech Dev; 2004 Oct; 121(10):1211-22. PubMed ID: 15327782
[TBL] [Abstract][Full Text] [Related]
77. Analysis of the human GDNF gene reveals an inducible promoter, three exons, a triplet repeat within the 3'-UTR and alternative splice products.
Grimm L; Holinski-Feder E; Teodoridis J; Scheffer B; Schindelhauer D; Meitinger T; Ueffing M
Hum Mol Genet; 1998 Nov; 7(12):1873-86. PubMed ID: 9811930
[TBL] [Abstract][Full Text] [Related]
78. Promoter hypermethylation is not the major mechanism for inactivation of the FBXW7 beta-form in human gliomas.
Gu Z; Inomata K; Mitsui H; Horii A
Genes Genet Syst; 2008 Aug; 83(4):347-52. PubMed ID: 18931460
[TBL] [Abstract][Full Text] [Related]
79. A 5'-CG-3'-rich region in the promoter of the transcriptionally frequently silenced RET protooncogene lacks methylated cytidine residues.
Munnes M; Patrone G; Schmitz B; Romeo G; Doerfler W
Oncogene; 1998 Nov; 17(20):2573-83. PubMed ID: 9840920
[TBL] [Abstract][Full Text] [Related]
80. Methylation of CpG island transcription factor binding sites is unnecessary for aberrant silencing of the human MGMT gene.
Pieper RO; Patel S; Ting SA; Futscher BW; Costello JF
J Biol Chem; 1996 Jun; 271(23):13916-24. PubMed ID: 8662860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
